Scalper1 News
Wedbush Securities and Maxim Group raised Illumina’s (ILMN) price targets a day after the maker of gene-sequencing systems reported fourth-quarter earnings that beat analysts’ views on a huge rise in EPS. Wedbush noted in a Jan. 28 post-earnings report that Illumina turned in Q4 results that showed its gene-sequencing business was doing even better than its pre-announcement of quarterly sales had suggested. The company pre-announced Q4 sales of Scalper1 News
Scalper1 News